Free Newsletter
Cipla offers generic Tamiflu for pandemic
Free newsletter via e-mail
Tools
Cipla, India's second-biggest drugmaker by market value, said it can supply 1.5 million doses of generic Tamiflu drugs to help fight an outbreak of swine flu. The company sells its copycat antiviral in India, and it says it can supply domestic and overseas governments within 4-6 weeks. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: